Sector valuations Indivior PLC London S.E.

Equities

Market Closed - London S.E. Other stock markets 11:35:04 2025-07-24 EDT			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		-.--%	-

01-08	Indivior PLC Provides Earnings Guidance for the Full Year 2026	CI
01-08	Indivior Expects Up to $1.20 Billion in 2026 Net Revenue	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	19.94x	1.78x	6.66x	3.08x	10.8x	16.82x	1.75%	66.64B
HALOZYME THERAPEUTICS, INC.	13.31x	11.93x	0.23x	6.89x	10.64x	11.31x	-	8.52B
KYOWA KIRIN CO., LTD.	24.14x	1.54x	-4.16x	2.36x	10.48x	14.05x	2.33%	8.51B
SK BIOPHARMACEUTICALS CO., LTD.	55.01x	13.38x	-2.02x	13.13x	41.38x	44.71x	-.--%	6.57B
YUHAN CORPORATION	67.81x	4.06x	0.9x	3.7x	42.26x	65.01x	0.44%	5.71B
BETTA PHARMACEUTICALS CO., LTD.	37.29x	3.46x	0.9x	6.31x	20.8x	35.56x	0.71%	3.05B
SUPERNUS PHARMACEUTICALS, INC.	-72.59x	-	0.47x	-	-	-	-	2.94B
KISSEI PHARMACEUTICAL CO., LTD.	18.03x	0.97x	-5.45x	1.59x	41.42x	-56.79x	2.48%	1.25B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	10.81x	1.93x	0.05x	-	-	-	0.93%	1.21B
OSCOTEC INC.	250.83x	14.1x	0.37x	35.05x	202.98x	256.4x	-	1.18B
HK INNO.N CORPORATION	35.3x	1.28x	0.69x	2.1x	18.59x	27.4x	-	1.01B
Average	41.81x	5.44x	-0.12x	8.24x	44.37x	46.05x	1.24%	9.69B
Weighted average by Cap.	24.98x	3.63x	3.76x	4.45x	17.43x	23.12x	1.57%